Publications by authors named "Rene Brunet"

Claim this Profile
O
Operational leeway in work situations: do ergonomic risk assessment tools consider operational leeway for job analysis?
Maxime Norval, Mohsen Zare, René Brunet, Fabien Coutarel, Yves Roquelaure

Int J Occup Saf Ergon· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three methods for evaluation of work postures in a truck assembly plant.
Mohsen Zare, Sophie Biau, Rene Brunet, Yves Roquelaure

Ergonomics· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of neck bending and flexion measurement methods for assessment of ergonomic risk.
Mohsen Zare, Sophie Biau, Rene Brunet, Antoine Gourlay, Yves Roquelaure

Int J Occup Saf Ergon· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for carpal tunnel syndrome related to the work organization: a prospective surveillance study in a large working population.
Audrey Petit, Catherine Ha, Julie Bodin, Pascal Rigouin, Alexis Descatha, René Brunet

Appl Ergon· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms.
Yves Bécouarn, Laurent Cany, Marina Pulido, Richard Beyssac, Patrick Texereau, René Brunet

BMC Res Notes· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients.
Audrey Laroche-Clary, Audrey Kauffmann, Denis Smith, Armelle Laurand-Quancard, Serge Evrard, René Brunet

Pharmacogenomics· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II study.
Marianne Fonck, Réné Brunet, Yves Becouarn, Jean-Louis Legoux, Jérôme Dauba

Clin Res Hepatol Gastroenterol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
Antoine Italiano, Isabelle Hostein, Isabelle Soubeyran, Thibault Fabas, Daniel Benchimol, René Brunet

Ann Surg Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could bipolar vessel sealers prevent bile leaks after hepatectomy?
Serge Evrard, Yves Bécouarn, René Brunet, Marianne Fonck, Caroline Larrue

Langenbecks Arch Surg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
Antonio Sa Cunha, Alexandre Rault, Christophe Laurent, Xavier Adhoute, Veronique Vendrely, René Brunet

J Am Coll Surg· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.
Chris J Twelves, Charles A Butts, Jim Cassidy, Thierry Conroy, Fillippo de Braud, Rene Brunet

Clin Colorectal Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
David Khayat, Olivier Rixe, René Brunet, Alain Goupil, Roland Bugat

Cancer Chemother Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Jim Cassidy, Josep Tabernero, Chris Twelves, René Brunet, Charles Butts

J Clin Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis